BG Medicine, Inc. (BGMD) – BGMD shares hit an intra-day high of $2.24 on Wednesday representing gains of roughly 23% since Tuesday’s closing price. The stock’s trading volume at 2,946,434 shares was considerably higher than average yesterday. The Company reported financial results for the fourth quarter and full year ended December 31, 2012 and provided an update on its progress in expanding the commercial adoption of its innovative diagnostic tests for cardiovascular disease. Product revenue from the BGM Galectin-3(R) test was $1.0 million in the fourth quarter of 2012, compared to $0.3 million in the same period in 2011. Total revenues increased to $1.1 million in the fourth quarter of 2012 compared to $0.4 million in the same period in 2011. Product margin was 70% in the fourth quarter of 2012, up from 60% in the fourth quarter of 2011. The stock has a 52-week trading range of 1.00 - 7.50.